Methods for treating neuropsychiatric disorders with nmda receptor antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20040122090A1
SERIAL NO

10250786

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions and methods for treating a human patient afflicted with a neuropsychiatric disorder. Specifically, the invention provides for compositions and methods of modulating or antagonizing the activity of neuronal NMDA receptors, wherein such antagonistic activity is capable of modulating the glutamate induced excitatory response of the neurons, thereby inhibiting an excitotoxic effect, promoting a neurotrophic effect, and thereby providing a therapeutic effect that treats the neuropsychiatric disorder.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NEUROMOLECULAR PHARMACEUTICALS INC1900 POWELL STREET SUITE 210 EMERYVILLE CA 94608

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Lipton, Stuart A Rancho Santa Fe, CA 47 676

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation